Valiante Salvatore, Prisco Marina, Sciarrillo Rosaria, De Falco Maria, Capaldo Anna, Gay Flaminia, Andreuccetti Piero, Laforgia Vincenza, Varano Lorenzo
Dipartimento delle Scienze Biologiche, Sezione di Biologia Evolutiva e Comparata, Università Federico II di Napoli, Via Mezzocannone, 8, 80134 Napoli, Italy.
J Endocrinol. 2008 Feb;196(2):291-303. doi: 10.1677/JOE-07-0127.
Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are regulatory neuropeptides of the hypothalamus-hypophyseal-adrenal axis, acting via the common receptors VPAC(1) and VPAC(2) and the selective PACAP receptor PAC(1). In the adrenal glands of the Italian wall lizard, Podarcis sicula, the presence of VIP in chromaffin cells, and the VIP-stimulated release of catecholamine and aldosterone in vivo, was previously shown. To examine the localization of both peptides and receptors and their mRNAs in the adrenal gland of P. sicula, immunohistochemistry and in situ hybridization were performed: PACAP and its mRNA were detected in chromaffin cells, VPAC(1) was found associated with steroidogenic tissue, VPAC(2) and PAC(1) with chromaffin tissue. Using 'far western blot' technique, we showed the presence of specific binding sites for VIP/PACAP in the adrenal glands of the lizard. The effects of both VIP and PACAP on the adrenal cells of the lizard were examined in vitro in adrenal cell co-cultures: both VIP and PACAP enhanced catecholamine, corticosterone and aldosterone release from adrenal cell co-culture in a time- and dose-dependent manner. The catecholamine release was inhibited by PAC(1) antagonist and in VPAC(2) immunoneutralized adrenal cells. The effects of VIP and PACAP on aldosterone secretion were counteracted by VPAC(1) antagonist administration in vitro. Corticosterone secretion elicited by VIP was not blocked by VPAC(1) antagonist, while the PACAP-induced release of corticosterone was blocked by the antagonist. Overall, our investigations indicate that these neuropeptides of the secretin superfamily can act not only as neurotransmitters but also as autocrine and paracrine regulators on chromaffin and cortical cells, being important mediators of the non-cholinergic system in the lizard adrenal gland.
血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽(PACAP)是下丘脑 - 垂体 - 肾上腺轴的调节性神经肽,通过共同受体VPAC(1)和VPAC(2)以及选择性PACAP受体PAC(1)发挥作用。先前已证明,在意大利壁蜥(Podarcis sicula)的肾上腺中,嗜铬细胞存在VIP,且VIP在体内可刺激儿茶酚胺和醛固酮释放。为了研究这两种肽及其受体以及它们的mRNA在意大利壁蜥肾上腺中的定位,进行了免疫组织化学和原位杂交:在嗜铬细胞中检测到PACAP及其mRNA,在类固醇生成组织中发现VPAC(1),在嗜铬组织中发现VPAC(2)和PAC(1)。使用“远免疫印迹”技术,我们证明了蜥蜴肾上腺中存在VIP/PACAP的特异性结合位点。在肾上腺细胞共培养物中体外研究了VIP和PACAP对蜥蜴肾上腺细胞的影响:VIP和PACAP均以时间和剂量依赖性方式增强了肾上腺细胞共培养物中儿茶酚胺、皮质酮和醛固酮的释放。PAC(1)拮抗剂和VPAC(2)免疫中和的肾上腺细胞可抑制儿茶酚胺释放。体外给予VPAC(1)拮抗剂可抵消VIP和PACAP对醛固酮分泌的影响。VIP诱导的皮质酮分泌不受VPAC(1)拮抗剂阻断,而PACAP诱导的皮质酮释放则被该拮抗剂阻断。总体而言,我们的研究表明,促胰液素超家族的这些神经肽不仅可以作为神经递质,还可以作为嗜铬细胞和皮质细胞的自分泌和旁分泌调节因子,是蜥蜴肾上腺非胆碱能系统的重要介质。